VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo

C. M. Lee, M. M. Hickey, C. A. Sanford, C. G. McGuire, C. L. Cowey, M. C. Simon, W. K. Rathmell

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences